Extensive review of pharmacokinetic and pharmacodynamic properties of ACE-inhibitors and angiotensin receptor blockers in hypertensive children

被引：0
|
作者：
Degraeuwe, Eva [1 ]
Sandra, Louis [2 ]
De Vos, Paulien [3 ]
Gasthuys, Elke [2 ]
Raes, Ann [1 ]
Walle, Johan Vande [3 ]
Vermeulen, An [2 ]
机构：
[1] Ghent Univ Hosp, Internal Med & Pediat, Ghent, Belgium
[2] Univ Ghent, Lab Med Biochem & Clin Anal, Fac Pharmaceut Sci, Ghent, Belgium
[3] Univ Ghent, Internal Med & Pediat, Ghent, Belgium
来源：
PEDIATRIC NEPHROLOGY | 2023年 / 38卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
P1-127
引用
收藏
页码：2318 / 2318
页数：1
相关论文
共 50 条
  • [31] Do Angiotensin II ATI Receptor Blockers and ACE-inhibitors Impact on Human Intestine Amino Acid Transporters via a Local Angiotensin System?
    Vuille-dit-Bille, Raphael
    Camargo, Simone
    Emmenegger, Luca
    Forras-Kaufmann, Zsofia
    Kuyumcu, Sena
    Fox, Marc
    Goetze, Oliver
    Schwizer, Werner
    Verrey, Francois
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S77 - S77
  • [32] Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome
    Yanqin Zhang
    Fang Wang
    Jie Ding
    Hongwen Zhang
    Xiaoyu Liu
    Suxia Wang
    Huijie Xiao
    Yong Yao
    Jingcheng Liu
    Xuhui Zhong
    Na Guan
    Baige Su
    Guohong Wu
    Lixia Yu
    Pediatric Nephrology, 2016, 31 : 67 - 72
  • [33] ACE-inhibitors/angiotensin receptor antagonists/diureticsHyperkalaemia and hypokalaemia: 10 case reports
    Reactions Weekly, 2017, 1641 (1) : 16 - 16
  • [34] Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome
    Zhang, Yanqin
    Wang, Fang
    Ding, Jie
    Zhang, Hongwen
    Liu, Xiaoyu
    Wang, Suxia
    Xiao, Huijie
    Yao, Yong
    Liu, Jingcheng
    Zhong, Xuhui
    Guan, Na
    Su, Baige
    Wu, Guohong
    Yu, Lixia
    PEDIATRIC NEPHROLOGY, 2016, 31 (01) : 67 - 72
  • [35] ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy
    M.-L. Gross
    A. El-Shakmak
    A. Szábó
    A. Koch
    A. Kuhlmann
    K. Münter
    E. Ritz
    K. Amann
    Diabetologia, 2003, 46 : 856 - 868
  • [36] ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy
    Gross, ML
    El-Shakmak, A
    Szábó, A
    Koch, A
    Kuhlmann, A
    Münter, K
    Ritz, E
    Amann, K
    DIABETOLOGIA, 2003, 46 (06) : 856 - 868
  • [37] Low-dose angiotensin receptor blockers as an alternative to ACE-inhibitors increase the risk of appropriate ICD interventions in heart failure
    Francia, Pietro
    Balla, Cristina
    Uccellini, Arianna
    Ricotta, Agnese
    Modestino, Anna
    Frattari, Alessandra
    Salvati, Adriano
    Volpe, Massimo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 145 (03) : 522 - 524
  • [38] A restrictive prescription policy contributes to underutilization of angiotensin-receptor-blockers among heart failure patients not receiving ACE-inhibitors
    Thanassoulis, George
    Humphries, Karin H.
    Tu, Jack V.
    Chen, Shun Fu
    Karp, Igor
    Pilote, Louise
    CIRCULATION, 2006, 114 (18) : 835 - 836
  • [39] Angiotensin II receptor blockers - Equal or preferred substitutes for ACE inhibitors?
    Grossman, E
    Messerli, FH
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (13) : 1905 - 1911
  • [40] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertensive African Americans
    Narayan, P
    Papademetriou, V
    Kokkinos, P
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 166A - 166A
12345